Embryonic stem cells have great potential in medicine, but the current methods used to grow them prevent their therapeutic use. A dual-action compound has been discovered that may help solve this problem.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Moore, H. Nature Biotechnol. 24, 160–161 (2006).
Chen, S. et al. Proc. Natl Acad. Sci. USA 103, 17266–17271 (2006).
Martin, M. J., Muotri, A., Gage, F. & Varki, A. Nature Med. 11, 228–232 (2005).
Ding, S., Gray, N. S., Wu, X., Ding, Q. & Schultz, P. G. J. Am. Chem. Soc. 124, 1594–1596 (2002).
Armstrong, L. et al. Hum. Mol. Genet. 15, 1894–1913 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Letso, R., Stockwell, B. Renewing embryonic stem cells. Nature 444, 692–693 (2006). https://doi.org/10.1038/444692b
Published:
Issue Date:
DOI: https://doi.org/10.1038/444692b
